Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Reindl

Showing results (1-10 of 248) with videos related to

Pageof 25
Sort By:
Ebiomedicine|September 5, 2019
Anti-thyroid autoantibodies as biomarkers for alemtuzumab associated thyroid autoimmunityMarkus Reindl
Neurology(R) Neuroimmunology & Neuroinflammation|December 11, 2020
Are aquaporin antibody titers useful outcome measures for neuromyelitis optica spectrum disorders?Markus Reindl
Journal of Neurology, Neurosurgery, and Psychiatry|November 28, 2017
Clinical course of MOG antibody-associated recurrent demyelinating diseasesMarkus Reindl
European Journal of Neurology|March 25, 2022
Guilty by association? SARS-CoV-2 antibodies and myelin oligodendrocyte glycoprotein antibody-associated diseaseRadu Tanasescu, Markus Reindl
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 25, 2023
Serum MOG IgG titres should be performed routinely in the diagnosis and follow-up of MOGAD: YesMarkus Reindl, Kevin Rostasy
Seminars in Immunology|February 21, 2026
Editorial: Autoimmune diseases of the central nervous systemSimone Mader, Markus Reindl
Neuropediatrics|October 30, 2013
Role of autoantibodies in acquired inflammatory demyelinating diseases of the central nervous system in childrenKevin Rostasy, Markus Reindl
Developmental Medicine and Child Neurology|March 4, 2016
Widening the spectrum of autoantibodies in pediatric brainstem encephalitisMelanie Ramberger, Markus Reindl
International Journal of Molecular Sciences|August 26, 2023
Blood-Brain Barrier Breakdown in Neuroinflammation: Current In Vitro ModelsSarah Brandl, Markus Reindl
The New England Journal of Medicine|May 4, 2007
Lack of association between antimyelin antibodies and progression to multiple sclerosisThomas Berger, Markus Reindl
Pageof 25

Showing results (1-10 of 248) with videos related to

Sort By:
Pageof 25
Ebiomedicine|September 5, 2019
Anti-thyroid autoantibodies as biomarkers for alemtuzumab associated thyroid autoimmunityMarkus Reindl
Neurology(R) Neuroimmunology & Neuroinflammation|December 11, 2020
Are aquaporin antibody titers useful outcome measures for neuromyelitis optica spectrum disorders?Markus Reindl
Journal of Neurology, Neurosurgery, and Psychiatry|November 28, 2017
Clinical course of MOG antibody-associated recurrent demyelinating diseasesMarkus Reindl
European Journal of Neurology|March 25, 2022
Guilty by association? SARS-CoV-2 antibodies and myelin oligodendrocyte glycoprotein antibody-associated diseaseRadu Tanasescu, Markus Reindl
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 25, 2023
Serum MOG IgG titres should be performed routinely in the diagnosis and follow-up of MOGAD: YesMarkus Reindl, Kevin Rostasy
Seminars in Immunology|February 21, 2026
Editorial: Autoimmune diseases of the central nervous systemSimone Mader, Markus Reindl
Neuropediatrics|October 30, 2013
Role of autoantibodies in acquired inflammatory demyelinating diseases of the central nervous system in childrenKevin Rostasy, Markus Reindl
Developmental Medicine and Child Neurology|March 4, 2016
Widening the spectrum of autoantibodies in pediatric brainstem encephalitisMelanie Ramberger, Markus Reindl
International Journal of Molecular Sciences|August 26, 2023
Blood-Brain Barrier Breakdown in Neuroinflammation: Current In Vitro ModelsSarah Brandl, Markus Reindl
The New England Journal of Medicine|May 4, 2007
Lack of association between antimyelin antibodies and progression to multiple sclerosisThomas Berger, Markus Reindl
Pageof 25